TELA Bio TELA Cash Flow Statement (2018-2026)

NASDAQ TELA
$0.88 -0.04 (-3.97%)
As of: Sep 10, 2026 · 12:31 PM EDT
Reported Financials

TELA Bio Quarterly Cash Flow Statement

Periods 32 quarters
Latest Jun 2026

TELA Bio reported cash from operations of -$9.38M and free cash flow of -$9.44M for the quarter ended Jun 2026, down 18.7% year over year. This cash flow statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-8.14M-8.58M-10.76M-11.17M-10.52M-10.61M-12.50M-11.66M-11.52M-13.62M-5.66M-12.60M-10.37M-9.97M-11.26M-9.92M-8.60M-1.26M-12.27M-11.26M
Share-based CompensationStock Comp.
1.71M0.82M1.89M1.96M2.01M1.04M2.22M2.22M2.20M1.24M2.28M2.24M2.13M1.09M2.54M2.82M2.66M0.81M3.54M3.49M
Deferred Taxes
0.05M0.03M7.23M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.65M0.10M0.84M0.35M0.62M0.06M0.58M0.13M0.29M0.42M0.56M0.35M0.66M1.39M0.63M0.28M0.63M0.82M0.94M0.30M
Cash from OperationsCash from Ops.
-6.63M-9.59M-10.43M-11.69M-7.65M-10.98M-11.57M-11.26M-6.97M-11.05M-14.38M-10.70M-8.98M-7.53M-9.72M-7.91M-5.72M-4.87M-11.17M-9.38M
Change in Working Capital
Change in ReceivablesChange Receivables
0.03M0.66M0.09M1.03M0.42M0.89M0.02M1.20M0.24M1.60M0.23M-0.50M2.01M-0.98M0.40M0.53M0.11M-0.93M-0.59M-0.09M
Change in InventoryChange Inventory
2.43M1.49M3.50M0.48M2.55M-0.47M3.86M-0.92M0.57M-0.79M1.43M0.12M0.81M0.62M1.35M-1.96M0.84M0.28M2.16M-0.86M
Change in Account PayablesChange Payables
1.02M0.01M3.27M-3.69M2.70M-3.17M3.66M-3.01M0.88M-1.52M1.51M-0.92M0.04M-0.15M1.85M-2.30M0.65M-0.06M1.59M-1.01M
Change in Accured ExpensesChange Accured Exp.
1.02M1.11M-1.92M2.14M0.58M1.60M-1.69M1.59M1.48M2.80M-3.47M0.85M1.66M-0.84M-0.93M1.39M0.63M0.66M-1.50M1.32M
Investing Activities
Capital ExpendituresCapex
0.28M0.29M0.34M0.20M0.29M0.05M0.12M0.16M0.13M0.20M0.30M0.30M0.12M0.26M0.03M0.11M0.21M0.09M0.12M0.06M
Sales of Property, Plant and EquipmentPP&E (Sale)
5.00M0.37M0.07M0.17M0.32M0.52M0.28M0.31M0.30M
Change in Acquisitions & DivestmentsChange Acquisitions
Cash from Investing ActivitiesCash from Investing
-0.29M-0.29M-0.34M-0.20M-0.29M-1.05M-0.12M-0.16M-0.13M-0.19M4.70M0.07M-0.12M-0.19M0.14M0.20M0.31M0.19M0.19M0.24M
Financing Activities
Other financing activitiesOther financing
0.26M0.14M0.01M3.35M0.10M0.04M0.06M0.00M0.03M0.22M0.01M0.06M0.06M0.04M3.45M0.03M
Cash from Financing ActivitiesCash from Financing
0.26M0.17M-0.15M6.65M34.57M-0.22M-0.23M46.41M0.07M0.02M0.06M-0.01M0.10M42.91M-0.12M-0.00M0.02M25.84M-0.30M-0.01M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.47M0.24M0.45M0.18M0.21M0.22M0.26M0.43M0.80M0.96M
Net Equity Issued and RepurchasedNet Equity Issued
46.30M-0.28M46.30M-0.01M
Additional items
Exchange Rate EffectFX Effect
0.01M-0.00M-0.00M-0.05M-0.13M0.04M0.03M0.15M-0.03M0.01M0.05M-0.01M-0.19M0.18M-0.13M-0.15M0.10M-0.04M-0.03M-0.01M
Change in Cash
-6.66M-9.71M-10.91M-5.29M26.50M-12.21M-11.89M35.14M-7.06M-11.21M-9.59M-10.65M-9.20M35.37M-9.84M-7.86M-5.28M21.13M-11.30M-9.17M
Free Cash FlowFCF
-6.91M-9.88M-10.77M-11.89M-7.94M-11.03M-11.69M-11.42M-7.10M-11.26M-14.69M-11.00M-9.11M-7.79M-9.76M-8.02M-5.93M-4.96M-11.29M-9.44M
Net Cash FlowNCF
-6.66M-9.70M-10.91M-5.24M26.63M-12.25M-11.92M34.99M-7.03M-11.22M-9.63M-10.63M-9.01M35.19M-9.70M-7.70M-5.38M21.17M-11.28M-9.16M